The mechanism of peptide-binding specificity of IAP BIR domains

Cell Death and Differentiation

Volumn 15, Issue 5, 2008, Pages 920-928

  Eckelman, B P ^a,b   Drag, M ^a,c   Snipas, S J ^a   Salvesen, G S ^a,b  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; NEURONAL APOPTOSIS INHIBITORY PROTEIN; PROLINE; X LINKED INHIBITOR OF APOPTOSIS;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; LIGAND BINDING; MOLECULAR LIBRARY; PREDICTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN TARGETING;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY;

EID: 42149087042     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2008.6     Document Type: Article

References (40)

1. Fuentes-Prior P, Salvesen GS. The protein shuctures that shape caspase activity, specificity, activation and inhibition. Biochem J 2004; 384: 201-232.
2. Salvesen GS, Duckett CS. IAP proteins: Blocking the road to death's door. Nat Rev Mol Cell Biol 2002; 3: 401-410.
3. Eckelman BP, Salvesen GS, Scott FL. Human inhibitor of apoptosis proteins: Why XIAP is the black sheep of the family. EMBO Rep 2006; 7: 988-994.
4. Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 2002; 9: 459-470.
5. Franklin MC, Kadkhodayan S, Ackerly H, Alexandru O, Distefano MD, Elliott LO et al. Structore and function analysis of peptide antagonists of melanoma inhibitor of apoptosis (ML-IAP). Biochemistry 2003; 42: 8223-8231.
6. Oost TK, Sun C, Armstrong RC, Al-Assaad AS, Betz SF; Deckwerth TL et al. Disoovery of potent antagonists of the andapoptotic protein XIAP for the treatment of cancer. J Med Chem 2004; 47: 4417-4426.
7. Sweeney MC, Wang X, Park J, Liu Y, Pei D. Determination of the sequence specificity of XIAP BIR domains by screening a combinatorial peptide library. Biochemistry 2006; 45: 14740-14748.
8. Liu Z, Sun C, Olejniczak ET, Meadows RP, Betz SF, Oost T et al. Structural basis for binding of Smac/DlABLO to the XIAP BIR3 domain. Nature 2000; 408: 1004-1008.
9. Wu G, Chai J, Suber TL, Wu JW, Du C, Wang X et al. Structural basis of IAP recognition by Smac/DIABLO. Nature 20OO; 408: 1008-1012.
10. Srinivasula SM, Datta P, Fan XJ, Fernandes-Alnemri T, Huang Z, Alnemri ES. Molecular determinants of the caspase-promoting activity of Smac/ DIABLO and Its role in the death receptor pathway. J Biol Chem 2000; 275: 36152-36157.
11. Srinivasula SM, Hegde R, Saleh A, Datta P, Shiozaki E, Chai J et al A conserved XIAP-interaction motif In caspase-9 and Smac/DlABLO regulates caspase activity and apoptosis. Nature 2001; 410: 112-116.
12. Scott FL, Denault JB, Riedl SJ, Shin H, Renatus M, Salvesen GS. XIAP inhibits caspase-3 and -7 using two binding sites: Evolutionarily conserved mechanism of IAPs. EMBO J 2005; 24: 645-655.
13. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE et al Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 2000; 102: 431-53.
14. Du C, Fang M, Li Y, Li L, Wang X. Smac, a mitochondrial protein to promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000; 102: 33-42.
15. Verhagen AM, Silke J, Ekert PG, Pakusch M, Kaufmann H, Connolly LM et al. HtrA2 promotes cell death through its serine protease activity and its to antagonize inhibitor of apoptosis proteins. J Biol Chem 2002; 277: 445-454.
16. Bangs P, Franc K White K. Molecular mechanism of cell death and phagocytosis in Drosophila. Cell Death Differ 2000; 7: 1027-1034.
17. Samuel T, Welsh K, Lober T, Togo SH, Zapata JM, Read JC, Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of TRAF2 and SMAC. J Biol Chem 2006; 281: 1080-1090.
18. Lin SC, Huang Y, Lo YC, Lu M, Wu H. Crystal structure of the BIR1 domain of XIAP in two crystal forms. J Mol Biol 2007; 372: 847-854.
19. Turk BE, Cantley LC. Using peptide libraries to identify optimal cleavage motifs for proteolytic enzymes. Methods 2004; 32: 398-405.
20. Eckelman BP, Salvesen GS. The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J Biol Chem 2006; 281 3254-3260.
21. Kipp RA, Case MA, Wist AD, Cresson CM, Carrell M, Griner E et al. Molecular targeting of inhibitor of apoptosis proteins based on small molecule mimics of natural binding partners. Biochemistry 2002; 41: 7344-7349.
22. Verhagen AM, Kratina TK, Hawkins CJ, Silke J, Ekert PG, Vaux DL. Identification of mammalian mitochondrial proteins that interact with IAPs via N-terminal IAP binding motifs. Cell Death Differ 2007; 14: 348-357.
23. Riedl SJ, Renatus M, Schwarzenbacher R, Zhou Q, Sun S, Fesik SW et al Structural basis for the inhibition of caspase-3 by XIAP. Cell 2001; 104: 791-800.
24. Kurakin A, Bredesen DE. An unconventional IAP-binding motif revealed by target-assisted iterative screening (TAIS) of the BIR3-cIAP1 domain. J Mol Recognit 2007; 20: 39-50.
25. Zachariou A, Tenev T, Goyal L, Agapite J, Steller H, Meier P. IAP-antagonists exhibit non-redundant modes of action through differential DIAP1 binding. EMBO J 2003; 22: 6642-6652.
26. Wu JW, Cocina AE, Chai J, Hay BA, Shi Y. Structural analysis of a functional DIAP1 fragment bound to grim and hid peptides. Mol Cell 2001; 8: 95-104.
27. Yan N, Wu JW, Chai J, Li W, Shi Y. Molecular mechanisms of DrICE inhibition by DIAP1 and removal of inhibition by Reaper, Hid and Grim. Nat Struct Mol Biol 2004; 11: 420-428.
28. Sun C, Cai M, Meadows RP, Xu N, Gunasekera AH, Herrmann J et al. NMR structure and mutagenesis of the third BIR domain of the inhibitor of apoptosis protein XIAP. J Biol Chem 2000; 275: 33777-33781.
29. Huang Y, Rich RL, Myszka DG, Wu H. Requirement of both the BIR2 and BIR3 domains for the relief of XIAP-mediated caspase inhibition by Smac. J Biol Chem 2003; 278: 49517-49522.
30. Gao Z, Tian Y, Wang J, Yin Q, Wu H, Li YM et al. A dimeric Smac/ diablo peptide directly relieves caspase-3 inhibition by XIAP. Dynamic and cooperative regulation of XIAP by Smac/Diablo. J Biol Chem 2007; 282: 30718-30727.
31. Bourhis E, Hymowitz SG, Cochran AG. The mitotic regulator survivin binds as a monomer to its functional interactor borealin. J Biol Chem 2007; 282: 35018-35023.
32. Zhang Y, Appleton BA, Wu P, Wiesmann C, Sidhu SS. Structural and functional analysis of the ligand specificity of the HtrA2/Omi PDZ domain. Protein Sci 2007; 16: 1738-1750.
33. Stiffler MA, Chen JR, Grantcharova VP, Lei Y, Fuchs D, Allen JE et al PDZ domain binding selectivity is optimized across the mouse proteome. Science 2007; 317: 364-369.
34. Paduch M, Biernat M, Stefanowicz P, Derewenda ZS, Szewczuk Z, Otlewski J. Bivalent peptides as models for multimeric targets of PDZ domains. Chembiochem 2007; 8: 443-452.
35. Polevoda B, Sherman F. N-Terminal acetyltransferases and sequence requirements for N-terminal acetylation of eukaryotic proteins. J Mol Biol 2003; 325: 595-622.
36. Martins LM, Iaccarino I, Tenev T, Gschmeissner S, Totty NF, Lemoine NR et al. The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J Biol Chem 2002; 277 439-444.
37. Hegde R, Srinivasula SM, Datta P, Madesh M, Wassell R, Zhang Z et al The polypeptide chain-releasing factor GSPT1/eRF3 is proteolytically processed into an IAP-binding protein. J Biol Chem 2003; 278 38699-38706.
38. Vucic D, Fairbrother WJ. The inhibitor of apoptosis proteins as therapeutic targets in cancer. Clin Cancer Res 2007; 13: 5995-6000.
39. Schimmer AD, Dalili S, Batey RA, Riedl SJ. Targeting XIAP for the treatment of malignancy. Cell Death Differ 2006; 13: 179-188.
40. Ostresh JM, Winkle JH, Hamashin VT, Houghten RA. Peptide libraries: determination of relative reaction rates of protected amino acids in competitive couplings. Biopolymers 1994; 34: 1681-1689.